.png){kind=icon}
C
Christopher G. Kanakry
H指数:33
被引数:5,049
浏览量:0
个人简介
暂无内容
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
Membranous Conjunctivitis in Acute and Chronic Graft-Versus-Host Disease: Longitudinal Ocular Outcomes
膜性结膜炎在急性与慢性移植物抗宿主病中的纵向眼部结局
Ocular Surface
IF5.6
Haploidentical versus matched unrelated donor transplantation with post-transplant cyclophosphamide: a platform-dependent machine learning analysis of donor age
单倍型与匹配无关供者移植联合移植后环磷酰胺：基于平台的机器学习分析供者年龄
Leukemia
IF13.4
Challenging a clinical dogma with multimodal machine learning: a retrospective analysis of transplant mismatched donor selection
以多模态机器学习挑战临床教条：移植不匹配供者选择的一项回顾性分析
Leukemia
IF13.4
Association of pharmacokinetic biomarkers with early immune recovery following HLA-haploidentical hematopoietic cell transplantation
HLA半相合造血干细胞移植后早期免疫重建与药代动力学生物标志物的关联
BK virus kinetics and associated cystitis/urethritis symptoms after PTCy-based allogeneic hematopoietic cell transplant
BK病毒动力学及PTCy为基础的异基因造血细胞移植后的膀胱炎/尿道炎症状
Blood Advances
IF7.1
Usefulness and Limitations of Polymerase Chain Reaction (PCR) for the Diagnosis and Management of Toxoplasmosis Following Allogeneic Hematopoietic Cell Transplant: Single-center Experience With 31 Patients Over 16 Years
聚合酶链式反应（PCR）在异基因造血细胞移植后弓形虫病诊断与管理中的有效性与局限性：单中心16年经验，涉及31例患者
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR
CD19嵌合抗原受体T细胞疗法治疗大B细胞淋巴瘤后的感染：CIBMTR的真实世界分析
Blood Advances
IF7.1
Choosing Between HLA-Mismatched Unrelated and Haploidentical Donors: Donor Age Considerations
选择HLA错配无亲缘关系供体与单倍型相同供体：供体年龄的考量
Role of Donor Cytomegalovirus Serostatus in Cytomegalovirus-Seronegative Recipients of Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide Prophylaxis
供者巨细胞病毒血清学状态在采用异基因供者造血细胞移植并接受术后环磷酰胺预防的巨细胞病毒血清学阴性受者中的作用
Genetic testing to identify hereditary predispositions to haematological malignancy is critical prior to allogenic haematopoietic cell transplant
进行遗传检测以识别对血液系统恶性肿瘤的遗传易感性，在异基因造血细胞移植前至关重要。
Understanding Barriers to Hematopoietic Cell Transplant (HCT) Access: Socio-Demographic Characteristics and Area Deprivation Index (ADI) of Patients Referred to the National Institutes of Health (NIH) for HCT
理解造血细胞移植（HCT）准入的障碍：转诊至美国国立卫生研究院（NIH）进行HCT的患者的社会经济特征及区域剥夺指数（ADI）
BLOOD
IF23.1
